Advertisements

Vasocard (Phenoxybenzamine)

Quick links to important sections

Vasocard (Phenoxybenzamine)

Advertisements
Advertisements

Method of action: Antihypertensive

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Vasocard (Phenoxybenzamine)

What is Vasocard (Phenoxybenzamine)?

Vasocard is a brand-name pharmaceutical preparation containing the active medicinal ingredient phenoxybenzamine. It belongs to a class of medications known as alpha-blockers, specifically categorized as a non-selective, irreversible alpha-adrenergic receptor antagonist.

Mechanism of Action

Phenoxybenzamine works by binding to alpha-receptors located on the walls of blood vessels. Under normal physiological conditions, these receptors respond to chemicals like adrenaline and noradrenaline, causing the blood vessels to tighten or constrict. By blocking these receptors, Vasocard prevents this constriction, allowing the blood vessels to relax and widen. This process, known as vasodilation, facilitates easier blood flow and reduces peripheral vascular resistance.

Primary Applications

Vasocard is primarily utilized in the management of complex hypertensive episodes and vascular dysfunction associated with specific conditions:

  • Pheochromocytoma: This is a rare type of vascular tumor, usually located in the adrenal glands, that secretes excessive amounts of hormones like epinephrine and norepinephrine. Vasocard is used to control blood pressure spikes caused by these hormonal surges, often as part of the preparation for surgical intervention.
  • Vascular Smooth Muscle Relaxation: Because its effects are long-lasting due to the irreversible nature of the bond it forms with receptors, it provides a stable reduction in the tension of the smooth muscles within the arterial system.

Unlike many other blood pressure medications that only provide temporary receptor blockage, the chemical bond formed by phenoxybenzamine is permanent. The body must synthesize new receptors to restore original function, which results in a prolonged duration of action.

Regulatory References

  1. Phenoxybenzamine Capsule Information (MedlinePlus, FDA)
  2. Phenoxybenzamine
  3. non-selective, irreversible alpha-adrenergic antagonist
  4. alpha-1 and alpha-2 adrenergic receptors
  5. vasodilation
  6. norepinephrine
Advertisements

What side effects are possible with Vasocard (Phenoxybenzamine)?

Possible Side Effects and Safety Information

The safety profile of Phenoxybenzamine is structured around the recognized effects of its pharmacological class, a non-selective alpha-adrenergic blocker. The majority of documented adverse reactions are categorized as having an Unknown Frequency, as regulatory data is insufficient to establish an accurate rate of occurrence.

Key adverse reactions are typically related to the blockade's effects on the vascular, cardiac, eye, and reproductive systems. Commonly listed effects include Postural Hypotension (dizziness upon standing), Reflex Tachycardia (increased heart rate), Nasal Congestion, Miosis (pinpoint pupils), and Inhibition of Ejaculation.

Regulatory Safety Constraints

The official labeling notes that adverse effects, such as drowsiness and fatigue, are more likely to manifest during the initiation of treatment or following a dose increase.

Serious Adverse Reactions officially documented include the risk of Orthostatic Syncope (fainting) and a specific caution regarding the potential association with carcinoma in humans following prolonged, long-term exposure.

Population-Specific Safety

Caution is formally advised for specific patient groups. Older adults may exhibit greater sensitivity to the hypotensive effects, necessitating careful use. Similarly, patients with pre-existing severe cerebral or coronary arteriosclerosis or renal impairment require particular attention, as the drug's effects may be undesirable or exaggerated in these conditions.

Use is contraindicated in conditions where a reduction in blood pressure is undesirable, such as recent acute myocardial infarction or cerebrovascular accident. The label also warns that combining Phenoxybenzamine with agents that stimulate beta-receptors (e.g., epinephrine) can lead to unopposed beta-adrenergic activity, resulting in an exaggerated drop in blood pressure.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Vasocard (Phenoxybenzamine) overdose primarily results in an exaggerated version of its therapeutic and side effects, stemming from a severe block of the sympathetic nervous system. Since phenoxybenzamine is a potent and long-acting alpha-blocker, overdose is a serious medical emergency.

Symptoms of Overdose

Symptoms of a Phenoxybenzamine overdose may include:

Symptom Category Potential Manifestations
Cardiovascular Profound Postural Hypotension (severe low blood pressure when standing), Reflex Tachycardia (fast heart rate, often in response to low blood pressure), and potentially Shock (a life-threatening condition due to insufficient blood flow).
Neurological Severe dizziness or fainting (syncope), lethargy, and possible confusion.
Gastrointestinal Vomiting.

When to Seek Emergency Help

Immediate medical attention is required if an overdose is suspected. Do not wait for symptoms to worsen. Call emergency medical services immediately if the person experiences any of the following:

  • Fainting or severe dizziness
  • Extremely fast heartbeat
  • Trouble breathing
  • Vomiting that is severe or persistent
  • Collapse or unresponsiveness

Treatment for overdose is supportive, focusing on managing blood pressure and heart rate, and is typically conducted in a hospital setting. Bring the medication container with you to the emergency room.

Advertisements

Therapeutic Uses of Vasocard (Phenoxybenzamine)

What Vasocard (Phenoxybenzamine) Treats: Main Uses and Benefits

Phenoxybenzamine is used for managing symptoms related to heightened physiological activity that involve severe, unpredictable episodes of high blood pressure and associated systemic issues, such as excessive sweating, which are characteristic manifestations of pheochromocytoma. Phenoxybenzamine is commonly used to help manage symptomatic periods associated with pheochromocytoma, a condition characterized by periods of heightened symptoms, and is considered relevant in conditions where symptomatic assistance is appropriate.

The medication is often applied in clinical settings that involve acute or unstable symptom patterns, such as preoperative stabilization before surgery, where it provides supportive relief by easing the pressure and assists with maintaining functional stability.

Its therapeutic relevance extends to two other primary domains: easing difficulties in urinary voiding, which addresses symptoms of neurogenic bladder dysfunction and functional outlet obstruction, and supporting management of severe vasospastic episodes in conditions like Raynaud's syndrome.

The medicine helps address symptom clusters that interfere with daily comfort and may assist with maintaining functional stability during difficult episodes.


Quick Fact: Relief for Voiding Difficulty The drug assists with maintaining functional stability by addressing symptoms of increased neurological or muscular activity in the lower urinary tract.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility for Vasocard (Phenoxybenzamine)

Official regulatory information defines specific populations that are either eligible, restricted, or prohibited from using Phenoxybenzamine. Eligibility is determined by official labeling that outlines contraindications and use limitations.

Contraindicated Populations (Must Not Use)

Phenoxybenzamine is contraindicated and must not be used by patients with a known hypersensitivity to the drug or any of its components. It is also prohibited in patients who have clinical conditions, such as shock, where any further or undesirable fall in blood pressure may pose a significant risk.


Populations Requiring Conditional Use

Use of Vasocard requires caution in specific populations:

  • Cardiovascular Conditions: Use is conditional in patients with marked cerebral or coronary arteriosclerosis.
  • Organ Impairment: Patients with existing renal damage or renal impairment must use the medication with caution.

Age and Reproductive Status

Population Regulatory Status
Pediatric Patients Safety and effectiveness have not been established in children.
Pregnancy Use is limited to situations only if clearly needed.
Lactation It is not known if the drug is excreted in human milk; a decision to discontinue nursing or the drug must be made.

Older adults may experience increased sensitivity, making dizziness or lightheadedness more likely.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Vasocard is primarily defined by pharmacodynamic risks stemming from its non-selective alpha-adrenergic blockade, as documented in official regulatory sources.

Interaction Entity Official Interaction Pattern
Epinephrine (Adrenaline) Contraindicated. Co-administration results in an exaggerated hypotensive response and tachycardia (epinephrine reversal) [Source 2.1].
Vardenafil (PDE5 Inhibitor) Contraindicated. Classified due to the high risk of severe hypotension via pharmacodynamic synergism [Source 3.2].
Sildenafil (>25 mg dose) Administration must be separated by at least four hours to mitigate the risk of symptomatic hypotension [Source 3.2].
Ethanol (Alcohol) The combination produces additive effects in lowering blood pressure [Source 1.1].
Yohimbe (Herbal product) Contraindicated due to risk of hypotension [Source 3.2].

Interacting medicinal product categories: This medicine may interact with other Alpha-1 Blocking Agents and Vasodilators, potentially enhancing the blood pressure-lowering effect through additive action [Source 4.3]. Compounds that stimulate both alpha- and beta-adrenergic receptors may interact to produce an exaggerated hypotensive response and tachycardia [Source 2.1]. The efficacy of phenoxybenzamine may be decreased when combined with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) [Source 1.4].

Population-Specific Cautions: The drug's effects and interaction risks may be increased in patients with officially documented renal damage or impairment, necessitating caution during administration [Source 4.2]. Similarly, patients with marked cerebral or coronary arteriosclerosis are noted in the regulatory text to require caution, as a drop in blood pressure may be undesirable [Source 4.2].

Advertisements

Mechanism of Action

The mechanism of action for Phenoxybenzamine centers on the non-competitive, irreversible blockade of alpha-adrenergic receptors. The drug acts as a non-selective antagonist, binding permanently to both alpha-1 (alpha1) and alpha-2 (alpha2) receptors via a stable covalent bond. This unique interaction physically occludes the receptor site, preventing activation by endogenous catecholamines, norepinephrine and epinephrine.

The alpha1 blockade on peripheral vascular smooth muscle interrupts the signaling cascade required for vasoconstriction (narrowing). This results in a generalized state of vasodilation (widening), which leads to decreased peripheral vascular resistance due to the suppression of constrictive signals.

Simultaneously, the blockade of presynaptic alpha2 autoreceptors disrupts the negative feedback mechanism that normally limits norepinephrine release. This disruption causes an increase in local neurotransmitter availability, contributing to associated system-level physiological adjustments, such as reflex changes in heart rate.

Advertisements

Dosage and Administration Information

How to Use Vasocard (Phenoxybenzamine) — Official Administration Guidelines

Phenoxybenzamine is provided as an oral capsule and must be taken by mouth. Official usage guidelines dictate a regimen of slow, incremental dose adjustment and specify constraints regarding the duration of use.


Dosing and Schedule Principles

Treatment must begin with a low initial dose that is slowly increased over time. The cumulative effects of daily administration influence the rate of dose adjustment.

Feature Official Instruction
Starting Dose (Adult) 10 mg of phenoxybenzamine hydrochloride, initially twice a day
Titration Interval Dosage should be increased every other day
Maintenance Range Usually 20 mg to 40 mg, divided into two or three daily doses
Duration Constraint Long-term use is not recommended

Administration and Special Populations

  • Dose Consistency: Patients should try to take the medicine at the same time each day. If gastrointestinal upset occurs, the medicine may be administered with milk.
  • Missed Dose: If a dose is missed, it should be taken as soon as possible, but if it is nearly time for the next scheduled dose, the missed dose should be skipped. It is specified that doses should not be doubled to compensate.
  • Pediatric Use: The dosage for children is based on body weight. The starting dosage is 0.2 mg/kg per day, which may be increased to a maintenance range of 0.4 mg/kg to 1.2 mg/kg per day, typically divided into three or four administrations.

These official instructions define the standardized procedural structure for starting and maintaining the therapy. The regimen emphasizes careful, gradual dose escalation to manage the cumulative effect of the drug while requiring a divided daily frequency.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Vasocard (Phenoxybenzamine)


Evidence for Use in Preoperative Stabilization

Phenoxybenzamine was studied for its role in the preoperative phase related to the surgical removal of tumors like pheochromocytoma and paraganglioma. These conditions are characterized by fluctuating or episodic manifestations, particularly sudden, severe changes in blood pressure. Researchers have utilized a combination of randomized controlled trials (RCTs)—which often compare it to other medicines in the same class—as well as comprehensive follow-up studies and reviews of patient outcomes.

The research examined measurements of systemic or functional imbalance, particularly blood pressure stability during and immediately after the surgery. Studies monitored the frequency of rapid, extreme blood pressure changes and the need for extra medications administered. Findings describe patterns observed in the studies regarding the cardiovascular system during these critical surgical phases. Limited information for long-term outcomes exists, as the primary focus of the evidence is on the immediate perioperative period.


Evidence for Use in Neurogenic Bladder Dysfunction

The research exploring Phenoxybenzamine in contexts of conditions associated with voiding difficulty—a condition marked by functional limitations—is primarily found in older, smaller clinical settings. The research examined what was measured regarding the ability of patients to empty their bladders and studies explored certain physiological measurements, such as the volume of urine remaining after voiding.

However, the evidence is limited and is mainly derived from studies that are several decades old and involved modest sample sizes. Certainty remains low, and comparative evidence is lacking against newer pharmaceutical options now commonly used.


What is Still Uncertain About Vasocard (Phenoxybenzamine) Research

The overall evidence base has several recognized limitations documented in scientific reviews. For instance, comparative evidence is lacking in several areas, as many older studies compared the drug to placebo or to no treatment, rather than to all modern alternatives. For conditions like neurogenic bladder and vasospasm, the evidence is largely historical, meaning that certainty remains low due to the scarcity of recent, large, well-controlled trials. Long-term effects are not fully established across all uses, and data for certain groups remain insufficient.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Vasocard (Phenoxybenzamine) (FAQ)


Q: How quickly does Vasocard start to work after taking it?

The blockade effect of this medicine is described as possibly beginning within about an hour of administration. However, because the medicine works to create a long-lasting blockade of receptors, the full effect on blood pressure may take several days to become fully established due to its cumulative action in the body.


Q: Is Vasocard meant to be taken for a long time, or only short-term?

Official information explicitly states that long-term use of phenoxybenzamine is not recommended. Its use is often limited to shorter treatment periods, such as the preoperative phase, with the duration determined by a prescribing professional.


Q: Why does the label warn about a possible risk of tumors in animals?

Regulatory documents report that studies conducted in rats and mice found that the drug increased the risk of developing certain malignant tumors. This finding is the basis for the formal caution against prolonged, long-term use documented in official prescribing information.


Q: What is the difference between Vasocard and other alpha-blockers like Doxazosin or Prazosin?

Vasocard is classified as a non-selective, irreversible alpha-adrenergic blocker. Official documents indicate that the drug forms a permanent bond with both alpha-1 and alpha-2 receptors. This non-selective and irreversible action is the primary characteristic distinguishing its mechanism within the class of alpha-blockers.


Q: Is it normal to feel tired or fatigued when starting Vasocard treatment?

Drowsiness, fatigue, and lack of energy are listed in the official documents as common or less common side effects. The official labeling notes that these effects are more likely to occur when treatment is first started or after the dose has been increased.


Q: Does Vasocard affect the eyes or cause problems with vision?

Yes, official documents list effects on the eye. A documented side effect is miosis, which is the medical term for pinpoint pupils. Blurred vision is also listed in regulatory safety profiles as a side effect.


Q: Does Vasocard lower blood pressure if a person does not have pheochromocytoma?

The drug's primary action, based on its pharmacology, is to block alpha receptors, leading to vasodilation (widening of blood vessels). This decrease in resistance in the vascular system is the mechanism by which blood pressure may be lowered.


Q: How does Vasocard prevent episodes of high blood pressure in pheochromocytoma?

This medicine works by creating a sustained blockade of the alpha-receptors on blood vessels. This action prevents high levels of the stress hormones epinephrine and norepinephrine from binding to the receptors that would otherwise cause sudden, severe vasoconstriction (blood vessel tightening) during an episode.


Q: Is Vasocard the same as other blood pressure medicines, like beta-blockers?

No, Vasocard (Phenoxybenzamine) is classified as an alpha-blocker, which is a distinct class of medicine from beta-blockers. Official warnings note that using the two classes of medicine together may involve certain risks, and their co-administration often requires a specific sequence or careful management by a professional.


Q: Are there any common over-the-counter pain relievers or cold medicines that interact with Vasocard?

Yes. Official product information cautions that certain nonprescription (over-the-counter) medicines for coughs, colds, pain, and appetite control should not be used without discussing it with a healthcare professional. These products may contain ingredients that interfere with the blood-pressure-lowering effects of Vasocard.


Q: What common foods or supplements should be avoided while taking Vasocard?

Official labeling instructs patients to discuss the use of this medicine with food with a healthcare professional. While specific food avoidance is not detailed in the general warnings, certain dietary changes may be necessary to manage potential side effects, such as continuous dry mouth.


Q: What medical conditions would prevent a person from taking Vasocard?

Regulatory documents list several conditions that prohibit use, including a known hypersensitivity (allergic reaction) to the drug. It is also contraindicated in situations where any further fall in blood pressure would be undesirable, such as in states of shock or immediately following a recent heart attack or stroke.


Q: What should be monitored, like blood pressure or heart rate, when taking Vasocard?

The official dosing guide states that the optimal dosage is determined by how well the patient's blood pressure is controlled. Therefore, patients are often advised to have their blood pressure checked regularly while taking this medication.


Q: What research is available on the long-term effects of Vasocard?

Regulatory documents contain explicit information regarding the potential association with carcinoma (cancer) in humans following prolonged, long-term exposure. This is one of the key long-term effect data themes available in official texts.


Q: What is the risk of having an allergic reaction to Vasocard?

The medicine is contraindicated and should not be used by patients with a known hypersensitivity. Signs of a potential allergic reaction listed in patient information include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.


Q: If I feel better, can I just stop taking Vasocard?

The treatment regimen for this medicine is characterized by a slow, careful, and gradual dose adjustment, which is managed by a healthcare professional. The decision to stop, start, or change the dosage should be discussed with them before any alteration is made.


Q: Is there a link between Vasocard and kidney problems?

Official documentation advises caution in patients who have pre-existing renal damage or kidney disease. The regulatory text warns that the effects of the drug may be increased or undesirable in this population.


Q: What should I tell a dentist or surgeon before a procedure if I am taking Vasocard?

Official patient instructions advise that patients should tell the medical doctor or dentist in charge of any surgery (including routine dental surgery) or emergency treatment that they are currently using this medicine.


Q: Will I need to change my diet while taking Vasocard?

Patients are officially instructed to discuss with a healthcare professional the use of the medicine with food or tobacco. Additionally, due to potential side effects like dry mouth, certain dental hygiene or dietary adjustments may be necessary.


Q: What is the chemical name for Vasocard?

The active ingredient is Phenoxybenzamine, which is typically found as the hydrochloride salt. The formal systematic chemical name is often cited in regulatory descriptions as N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine hydrochloride.


Q: Does Vasocard change how alert I feel, and should I avoid driving?

This medicine may cause some people to become dizzy, drowsy, or less alert. Official patient warnings caution individuals to avoid activities requiring mental alertness, such as driving or operating machinery, until they understand how the medicine may affect them.


Q: What are the signs of taking too much Vasocard (overdose symptoms)?

Regulatory documents on overdosage list signs that are related to the severe blockade of the nervous system. These symptoms may include postural hypotension (dizziness or fainting), tachycardia (fast heart rate), vomiting, lethargy (sluggishness), and potentially shock.


Q: What does it mean that Vasocard can produce a 'chemical sympathectomy'?

The FDA label explicitly states that the medicine is a long-acting alpha-receptor blocking agent that can produce and maintain 'chemical sympathectomy' through oral use. This term refers to the profound and sustained blockade of the part of the nervous system (sympathetic) that controls blood vessel tightening.


Q: Does Vasocard affect my body temperature or cold tolerance?

Official patient information notes that the drug’s blocking effect may suppress the body’s ability to generate heat and may reduce tolerance to cold temperatures. This is a specific caution, especially noted for older adult patients.


Q: Does Vasocard interact with any psychiatric or mood disorder medications?

Official drug interaction checkers list potential interactions with multiple classes of psychiatric and mood disorder medications. These include certain antidepressants and other compounds that affect the central nervous system, meaning they require professional guidance to avoid compounding effects.

Advertisements

How should Vasocard (Phenoxybenzamine) be stored and disposed of?

Storage and Disposal for Phenoxybenzamine Hydrochloride Capsules

Phenoxybenzamine hydrochloride capsules must be stored according to specific regulatory requirements to maintain product stability and safety. The medication is required to be stored at Controlled Room Temperature, which is 25 C (77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F).

  • Container and Environment: The capsules must be kept in the container it came in, which must be tightly closed. Storage areas should protect the product from excess heat, moisture, and freezing; it is advised not to store the medication in the bathroom.
  • Child Safety: The medication must be kept securely out of the sight and reach of children.
  • Disposal: Unneeded or expired capsules must not be flushed down the toilet. Disposal should be carried out through a medicine take-back program or by following the regulated household trash disposal method: mixing the product with an unappealing substance and sealing it in a bag before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vasocard (Phenoxybenzamine) found in:

A-Z Index: